Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;51(7):e13534.
doi: 10.1111/eci.13534. Epub 2021 Mar 11.

The role of statins in the differentiation and function of bone cells

Sajad Chamani  1   2 , Luca Liberale  3   4 , Leila Mobasheri  5 , Fabrizio Montecucco  4   6 , Khalid Al-Rasadi  7 , Tannaz Jamialahmadi  8   9 , Amirhossein Sahebkar  10   11   12   13
Affiliations
Review

The role of statins in the differentiation and function of bone cells

Sajad Chamani et al. Eur J Clin Invest. 2021 Jul.

Abstract

Background: Statins are 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors blocking cholesterol biosynthesis in hepatic cells, thereby causing an increase in low-density lipoprotein (LDL) receptors resulting in enhanced uptake and clearance of atherogenic LDL-cholesterol (LDL-C) from the blood. Accordingly, statins decrease the risk of developing atherosclerosis and its acute complications, such as acute myocardial infarction and ischaemic stroke. Besides the LDL-C-lowering impact, statins also have other so-called pleiotropic effects. Among them, the ability to modulate differentiation and function of bone cells and exert direct effects on osteosynthesis factors. Specifically, earlier studies have shown that statins cause in vitro and in vivo osteogenic differentiation.

Design: The most relevant papers on the bone-related 'pleiotropic' effects of statins were selected following literature search in databases and were reveiwed.

Results: Statins increase the expression of many mediators involved in bone metabolism including bone morphogenetic protein-2 (BMP-2), glucocorticoids, transforming growth factor-beta (TGF-β), alkaline phosphatase (ALP), type I collagen and collagenase-1. As a result, they enhance bone formation and improve bone mineral density by modulating osteoblast and osteoclast differentiation.

Conclusion: This review summarizes the literature exploring bone-related 'pleiotropic' effects of statins and suggests an anabolic role in the bone tissue for this drug class. Accordingly, current knowledge encourages further clinical trials to assess the therapeutic potential of statins in the treatment of bone disorders, such as arthritis and osteoporosis.

Keywords: bone; osteoblast; osteoclast osteogenesis; statins.

PubMed Disclaimer

References

REFERENCES

    1. Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Med Clin (Barc). 2018;150(10):398-402.
    1. Toth PP, Banach M. Statins: then and now. Methodist Debakey Cardiovasc J. 2019;15(1):23-31.
    1. Mach F, Ray KK, Wiklund O, et al. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39(27):2526-2539.
    1. Tian L, Yu X. Lipid metabolism disorders and bone dysfunction-interrelated and mutually regulated. Mol Med Rep. 2015;12(1):783-794.
    1. Alekos NS, Moorer MC, Riddle RC. Dual effects of lipid metabolism on osteoblast function. Front Endocrinol. 2020;11:578194.

MeSH terms

LinkOut - more resources